Valeant says FDA denies approval to nail infection drug

(Reuters) – Canada drugmaker Valeant Pharmaceuticals International said on Tuesday that the U.S. Food and Drug Administration denied approval for its drug to treat onychomycosis, a fungal infection of the nail. Reuters: Health News http://healthmedicinet.com/i/valeant-says-fda-denies-approval-to-nail-infection-drug/